Skip Content
You are currently on the new version of our website. Access the old version .
PharmaceuticalsPharmaceuticals
  • Correction
  • Open Access

6 December 2021

Correction: Tickner, Z.J.; Farzan, M. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors. Pharmaceuticals 2021, 14, 554

and
1
Department of Immunology and Microbiology, The Scripps Research Institute, Jupiter, FL 33458, USA
2
Emmune, Inc., Jupiter, FL 33458, USA
*
Author to whom correspondence should be addressed.
This article belongs to the Special Issue Potential of the Aptamers to Fill Therapeutic and Diagnostic Gaps

Missing Citation

In the original article, Renzl, C.; Kakoti, A.; Mayer, G. Aptamer-Mediated Reversible Transactivation of Gene Expression by Light. Angew. Chem. Int. Ed. 2020, 59, 22414, doi:10.1002/anie.202009240 was not cited [1]. The citation has now been inserted in Section 2.8: Regulation of CRISPR-Cas Activity by Riboswitches, paragraph 2, and should read: A particularly interesting case was recently reported by Renzl et al., who incorporated aptamers to the photoreceptor PAL into gRNAs and demonstrated 546-fold regulation of mRNA levels in response to light in HeLa cells [190].

Reference

  1. Tickner, Z.J.; Farzan, M. Riboswitches for Controlled Expression of Therapeutic Transgenes Delivered by Adeno-Associated Viral Vectors. Pharmaceuticals 2021, 14, 554. [Google Scholar] [CrossRef] [PubMed]
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Article Metrics

Citations

Article Access Statistics

Multiple requests from the same IP address are counted as one view.